Search

everythinglearnresearchcommunity

for

Search:↓

Vesicles made of behenyltrimethylammonium chloride and stearic acid can triple the skin absorption of hinokitiol, which may help with hair growth.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Stem cells help remove dead cells to keep tissues healthy by balancing cell replacement and clearance.

Silicone oil viscosity affects hair curling and damage during treatments.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

There is no standard treatment for CCCA, and practices vary widely.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

The combination therapy was effective and well-tolerated, especially in young patients.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

BTA safely and effectively treats hair loss, and works better with FNS.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.